A specific association with mixed lineage leukemias suggests that MLL oncoproteins may selectively target early multipotent hematopoietic progenitors or stem cells. We demonstrate here that a representative MLL fusion protein, MLL-GAS7, impairs the differentiation and enhances the in vitro growth of murine hematopoietic cells with multipotent features. The multilineage differentiation potential of these cells was suggested by their immuno-phenotypes and transcriptional programs and confirmed by their ability to induce three pathologically distinct leukemias in mice, including an acute biphenotypic leukemia (ABL) that recapitulates the distinctive hallmark features of many MLL-associated leukemias in humans. This experimental modeling of ABL in mice highlights its origin from multipotential progenitors that arrest at a bipotential stage specifically targeted or induced by MLL oncogenes.
Introduction
MLL oncoproteins may transform early progenitors of either the myeloid or lymphoid lineages, but leukemias with unusual Chromosomal rearrangements of the Mixed Lineage Leukemia biphenotypic (ABL) features may result from so-called "lineage (MLL) gene are associated with a subset of de novo and secondinfidelity" representing aberrant expression of lineage-associary acute leukemias of both children and adults (Djabali et al., ated genes (McCulloch, 1983) . Alternatively, MLL oncoproteins 1992; Gu et al., 1992; Tkachuk et al., 1992) . As a consequence, may target hematopoietic cells with multilineage differentiation MLL undergoes fusions with a wide variety of partner genes to potential, such as hematopoietic stem cells (HSC) (Morrison yield a plethora of chimeric proteins in leukemias of either myand Weissman, 1994) , their immediate downstream progeny, eloid or lymphoid derivation (Ayton and Cleary, 2001 for review).
the multipotent progenitor (MPP) (Morrison et al., 1997) , or proThe remarkable variety of MLL fusion partners (up to 50) and genitors with bilineage potential (Cumano et al., 1992; Montecino-Rodriguez et al., 2001) . In this scenario, ABL may recatheir diverse lineage associations contrast with most other chimeric leukemia oncoproteins, which are not as variable and tend pitulate otherwise normal phenotypes of early progenitors expressing dual lineage markers, a phenomenon called "lineage to be specific for leukemias of a single lineage. Furthermore, a hallmark feature of many MLL-associated leukemias is the copromiscuity" (Greaves et al., 1986) . Elucidation of their origin will further an understanding of the unique biology and etiology expression of both myeloid and lymphoid antigens representative of a biphenotypic or mixed lineage derivation (Chen et al., of mixed lineage leukemias, which are generally associated with a poor clinical prognosis (Chen et al., 1993; Pui et al., 2002) . 1993), hence the name MLL (McCabe et al., 1992) . In addition to their unique phenotypes, MLL biphenotypic leukemias also Several animal models have been employed to study the biological roles of MLL oncoproteins in leukemogenesis. display transcriptional programs distinct from those displayed by myeloid or lymphoid acute leukemias, respectively (ArmKnockin of AF9 into the Mll locus by homologous recombination resulted in acute leukemias preceded by myeloproliferation that strong et al., 2002; Yeoh et al., 2002) .
Two alternative, but not mutually exclusive, mechanisms mimics the corresponding human disease (Corral et al., 1996; Dobson et al., 1999) . Similarly, retroviral transduction/transhave been proposed to account for mixed lineage features.
S I G N I F I C A N C E
A hallmark feature of many human leukemias that harbor mutations of the MLL oncogene is the co-expression of myeloid and lymphoid antigens representative of a biphenotypic or mixed lineage derivation. We demonstrate that transduction of hematopoietic cells with features of multipotent progenitors by an MLL oncogene resulted in multilineage leukemias, including acute myeloid, lymphoid, and biphenotypic leukemias, that closely recapitulate the corresponding human diseases. By prospectively isolating and transducing highly purified populations of hematopoietic stem cells and progenitors, we further demonstrate that stem cells, but not myeloid or lymphoid committed progenitors, yield multilineage oncogenic readouts. These studies suggest that the unusual pathologic and clinical features of MLL-associated leukemias result in part from selective oncogenic effects of MLL on multipotent progenitors, consistent with a "lineage promiscuity" model for the pathogenesis of mixed lineage leukemias.
yielded leukemias with myeloid/lymphoid biphenotypic features. It is therefore still largely unknown how MLL oncoproteins result in multilineage leukemias in humans.
We report here that a representative MLL fusion protein (MLL-GAS7) impairs the differentiation and enhances the in vitro growth of murine hematopoietic cells with features of MPP. Transformed MPP-like cells induced leukemias of multiple lineages in syngeneic mice including an acute biphenotypic leukemia (ABL) expressing both myeloid and lymphoid antigens and genes. Biphenotypic progenitors were also generated in vitro from HSC transduced with MLL-GAS7. This represents a successful modeling of ABL in mice and highlights its origin from a previously undefined biphenotypic progenitor that may be specifically affected by MLL oncogenes.
Results

Induction of mixed lineage leukemias by MLL-GAS7
Primary murine hematopoietic cells enriched for HSC and early progenitors (c-kit ϩ fraction) were transduced with recombinant retroviruses encoding MLL-GAS7 and then directly transplanted into lethally irradiated, syngeneic mice ( Figure 1A ). All mice succumbed to leukemias within 5 months ( Figure 1B ). The leukemias were oligoclonal as judged by proviral integration status ( Figure 1C ), suggesting that MLL-GAS7 required few additional mutations to induce leukemia in mice. Most (80%) of the leukemias were AMLs based on phenotypic (c-kit
) and cytologic features. One was ALL as evidenced by its immunophenotype (c-kit
) and presence of Ig heavy chain gene rearrangements ( Figure 1C and data not shown). Notably, one of the leukemias appeared to be of mixed lineage containing a subset of cells in the bone marrow that displayed bilineage (c-kit Figure 1C ), as well as cells expressing exclusively myeloid antigens. At several extramedullary sites of this mouse, only monoclonal myeloid leukemic cells were present, suggesting that multiclonal leukemias arose in the bone marrow from which individual leukemic clones disseminated to peripheral sites ( Figure 1C ). These observations suggested that MLL-GAS7 is directly capable of inducing leukemias of different duced with recombinant retroviruses encoding MLL-GAS7, or the respective portions of MLL (5Ј-MLL) or GAS7 (GAS7) (Figures 1A and 2A) . Plating of transduced cells in methylcellulose yielded similar numbers of G418-resistant colonies for each of plantation assays have also successfully modeled the transforthe constructs, indicating comparable transduction efficiencies. mation properties of various MLL fusion proteins (Lavau et al., Cells transduced with MLL-GAS7 showed enhanced growth , 2000 Luo et al., 2001; DiMartino et al., 2002, So and potential as evidenced by continued ability to generate com- Cleary, 2002 Cleary, , 2003 . However, both experimental approaches are highly biased toward myeloid leukemias, and none has pact, immature CFU-blast colonies upon serial replating in methylcellulose culture (Figure 2A ). Cells harvested from second and phenotypic features (Table 1 and Figure 3C ) that defined three specific subtypes. These were: (1) AML with features of or third round methylcellulose cultures (200-400 pooled coloearly myeloid precursors (c-kit ϩ /Mac-1 ϩ /Gr-1 ϩ /B220 Ϫ /CD19 Ϫ ); nies) gave rise to long-term growth of clonal populations in (2) ALL with features of early B-lymphoid precursors (c-kit ϩ / liquid medium. Interestingly, their immunophenotypes showed CD43 ϩ /B220 ϩ /BP-1 ϩ /CD19 ϩ /Mac-1 Ϫ /Gr-1 Ϫ ); and (3) acute bihigh level co-expression of c-kit and Sca-1 ( Figure 2B ), a characphenotypic leukemia (ABL) comprised of blasts co-expressing teristic phenotype of HSC and MPP (Morrison and Weissman, both myeloid and lymphoid markers (c-kit Morrison et al., 1997) . They were negative for most lin-
The leukemia subtypes were similar to those eage-specific markers tested (Gr-1, CD19, Ter119, CD8) except resulting from the direct transplant experiments (Figure 1 ) indi-B220 lo and Mac-1, which also can be expressed by MPP (Morcating that this was a reproducible feature of MLL-GAS7-rison et al., 1997). These data suggested that MLL-GAS7 eninduced leukemias. Although the leukemic cells from all three hanced the in vitro growth of cells with some features of MPP.
subtypes lacked expression of Sca-1, which distinguished them We will therefore refer to them as MPP-like based on their from the injected MPP-like cells, all subtypes displayed identical phenotypic and functional (defined below) properties.
genomic configurations of the integrated MSCV/MLL-GAS7 provirus on Southern blot analysis ( Figure 3C ), indicating that Transformed MPP-like cells induce leukemias they derived from a single clone of cells and not from rare, of diverse lineages genetically distinct subclones that may have been present in Transduced cells clonally expanded from in vitro cultures dethe original culture. scribed above were assessed for their leukemogenic potential
The different lineage derivations of the leukemias were furin sub-lethally irradiated, syngeneic C57BL/6 mice. Within a ther confirmed by immunoglobulin (Ig) gene rearrangement starelatively short latency period (mean 3 months) similar to that tus. AML cells maintained germline configurations for IgH genes observed above for in vivo experiments, all animals succumbed whereas ALL cells displayed IgH gene rearrangements in the to acute leukemias that expressed the MLL fusion protein (Fig- absence of light chain gene rearrangements ( Figure 3C and data not shown), suggesting an arrest at a late pro-B (fraction C) ures 3A and 3B). The leukemias exhibited diverse pathologic stage of differentiation (Hardy et al., 1991) . ABL cells displayed versely, mice with ALL had extensive involvement of lymph nodes and thymus, but only moderate liver and spleen infiltrates. germline configurations for the IgH gene, consistent with maturation arrest at a stage prior to initiation of the rearrangement Mice with ABL typically displayed composite features with lymph node as well as liver and spleen enlargement. AML was process.
The leukemia subtypes were also characterized by distincassociated with very high peripheral blood cell counts and circulating blasts, while ABL and ALL displayed modestly elevated tive pathologic presentations ( Figure 4 and Table 1 ). Mice with AML displayed massive leukemic infiltration in the liver and blood cell counts and fewer blasts (Table 1 ). Taken together, these studies indicated that cells transformed in vitro by MLLspleen, but no involvement of other lymphoid organs. Con- GAS7 with MPP-like features were capable of inducing three tirely different set of genes including GATA-2, GATA-3, and SCL, but were notable for their lack of expression of the above different leukemias in vivo.
myeloid genes. Interestingly, ABL cells expressed genes common to both myeloid and lymphoid progenitors. While the con-AML, ALL, and ABL display distinct trasting expression profiles exhibited by AML and ALL reflected gene expression profiles their lineage-specific origins, co-expression of both lymphoid Hematopoietic lineage commitment is regulated in part by the and myeloid genes in ABL suggested maturation arrest at a more functional balance of transcription factors, which turn on/off specific lineage-defining genes. Thus Immunophenotype and genotype analyses revealed that half the mice had AML and half had ALL ( Figure 6B ). All leukemias displayed configurations of proviral integration sites that were Multilineage transformation arises from multipotential identical to the injected biphenotypic cells as well as the parental progenitors but not committed myeloid MPP-like cells, indicating that they were derived from a single or lymphoid progenitors clone of transduced cells. These studies suggested that transTo identify normal progenitors susceptible to MLL-induced formed MPP-like cells were capable of sequentially differentiatmultilineage oncogenic readouts, in vitro transformation assays ing into biphenotypic progenitors with the capacity to further were performed using purified populations of known phenotypidifferentiate along either the myeloid or lymphoid lineages to cally defined progenitor cells. HSC, common lymphoid progenitors (CLP), common myeloid progenitors (CMP), granulocyte/ induce AML or ALL, respectively. preceding section above, while transformed CMP and GMP (Figure 7 ). These colonies were heterogenous in appearance, varying from densely compact to diffuse, and were composed of plating (Figure 7) , they failed to replate (Table 2) . These results b CLP gave only transient readout in the second round of serial plating.
indicate that committed myeloid or lymphoid progenitors are n.a., not applicable due to lack of progenitor colony formation under in vitro conditions at second or third rounds of serial plating.
not the targets for multilineage readouts induced by MLL-GAS7, and only transduced HSC that are capable of differentiating into MPP can give rise to transformed biphenotypic progenitors.
Discussion monocyte progenitors (GMP), and megakaryocyte/erythocyte progenitors (MEP) were isolated by FACS based on their surface
In the present study, we demonstrate the induction of mixed phenotypes (Kondo et al., 1997; Akashi et al., 2000) . Purified lineage leukemias by an MLL oncogene. These leukemias apcells were transduced with retroviruses and subjected to serial peared to result from a primary effect of MLL-GAS7 to impair the replating analysis in methylcellulose medium containing cytodifferentiation of cells with features of multipotent hematopoietic kine cocktails that favored myeloid or lymphoid differentiation progenitors. MLL-GAS7 enhanced the in vitro clonogenic prop-( Figure 1A ). Under myeloid culture conditions, transduced HSC, erties of Sca-1 ϩ /c-kit ϩ /lin Ϫ/lo cells under conditions where pro-CMP, and GMP generated colonies through the third round of genitors normally exhaust their growth potential and undergo serial plating (Table 2) (Table 2 and data not shown) similar to those described in the Arrows indicate the morphology of specific cell populations that were FACS-purified based on their surface marker expression and stained with Wright-Giemsa (magnification ϭ 800ϫ). The purified stem/progenitor populations that were transduced with MLL-GAS7 to initiate the cultures are indicated on the left. Culture conditions (indicated to the right) were optimized by specific cytokine cocktails, for growth of lymphoid (IL-7, SCF, Flt-3L) or myeloid (IL-3, IL-6, GM-CSF, SCF) progenitors.
Mac1 lo
) without detectable self-renewal potential (Morrison and Weissman, 1994; Morrison et al., 1997; Christensen and Weissman, 2001 ). These represent the most primitive populations of defined progenitors with potential to differentiate into all known hematopoietic cell lineages (Morrison et al., 1997) . The progenitors affected by MLL-GAS7 in vitro are most comparable (but not identical) phenotypically to MPP, the direct progeny of shortterm HSC. The multilineage differentiation potentials of the transformed cells were suggested by their transcriptional programs and confirmed by an ability to induce leukemias of three different lineages in mice. MLL-GAS7 also induced multilineage readouts from purified HSC in vitro, indicating that both HSC and MPP are potential targets for the induction of mixed lineage leukemias by MLL oncogenes.
MLL-GAS7 appears particularly potent at altering the growth properties of MPP-like cells compared to other MLL fusion proteins by mechanisms that remain undefined. We have observed that MLL-ENL is also capable of inducing the outgrowth of biphenotypic progeny from purified HSC under in vitro lymphoid culture conditions, but it is significantly less effective than MLL-GAS7 (data not shown). Recently, MLL-ENL was reported to transform chicken cells with phenotypic features of MPP (Schulte et al., 2002) . Their differentiation potential, however, was restricted to the myeloid lineage and they failed to induce lymphoid leukemias, further suggesting that MLL-ENL strongly favors myeloid transformation in vivo consistent with our recent observations using purified progenitor subsets (A. Cozzio et al., submitted). Thus, despite the targeting of MLL oncogenes to multipotent progenitors, specific fusion partners appear to heavily influence the actual features of MLL-associated leukemias presumably through interactions with lineage-specific factors.
Although the in vitro growth and differentiation properties of MPP/HSC are perturbed by MLL oncogenes, the resultant Similarly, stem cell leukemia is not a feature of AML1-ETO positive patients in spite of expression of the fusion gene in the HSC compartments . Taken together, these studies suggest a model in which MLL fusion genes might progenitors . Conversely, biphenotypic ABL enhance the self-renewal potential of multipotent progenitors cells and MPP-like cells expressed a broader range of genes that otherwise retain an ability to differentiate into downstream common to both the myeloid and lymphoid lineages. These progeny. The latter may be more susceptible to the differentiaobservations are consistent with the proposed multilineage tion blocking effects of MLL oncoproteins or more prone to priming feature of uncommitted progenitors, which express develop the secondary mutations required for complete leuketranscripts for most of the known key transcription factors, mogenic transformation (Figure 8) .
growth factor receptors, and other genes encoding lineageConsistent with the above model, transduced Sca-1 ϩ /c-kit ϩ exclusive functions (Hu et al., 1997; Enver and Greaves, 1998) . progenitors gave rise to biphenotypic progeny in vitro and, when Under this model of hematopoietic differentiation, unilineage transplanted, to biphenotypic leukemias (ABL) in vivo (in addicommitment is achieved by specific upregulation of genes for tion to AML and ALL). Gene expression profiling studies of the one particular lineage and downregulation of genes for all other leukemic cells were consistent with immunophenotype and Ig lineages. We hypothesize that activating mutations of MLL, genotype analyses on defining three distinct lineage derivations which is genetically implicated in maintaining normal developof the leukemias. Genes required for myeloid development, such mental gene expression, may oppose unilineage differentiation as GM- CSF-R, M-CSF-R, and G-CSF-R (Zhu and Emerson, by preventing the downregulation of genes involved in main-2002), were expressed by AML but not ALL cells. The latter taining the multipotentiality of HSC/MPP. Our limited transcripexpressed a different non-overlapping set of genes including GATA3, which is expressed by normal CLP but not myeloid tional profiling studies are also consistent with recent studies of AML, respectively (Armstrong et al., 2002; Yeoh et al., 2002) . HSC, CLP, CMP, GMP, and MEP, bone marrow cells from 4-to 8-weekold mice were stained with specific conjugated and unconjugated antibodies DNA constructs as previously described (Morrison and Weissman, 1994; Kondo et al., 1997 ; A full-length GAS7 cDNA was amplified by RT-PCR using primers based on Morrison et al., 1997; Akashi et al., 2000) and double-sorted using the FACS the published sequence (accession number AB007854) (Megonigal et al., Vantage. 2000) . The resulting GAS7 cDNA was inserted into the NruI and XhoI sites of MSCV-neo-MLL5Ј (DiMartino et al., 2002) in-frame with MLL amino acids Genotype analyses 1-3696 to yield an MSCV/MLL-GAS7 fusion construct, which was seGenomic configurations of Ig genes and retroviral integrations were deterquenced to exclude mutations introduced by PCR. mined by Southern blot analyses. Genomic DNAs were extracted from tumor tissues/cells and digested with appropriate restriction enzymes (XbaI for Ig In vitro and in vivo transformation assays gene rearrangement; BamHI or BamHI/ScaI for viral integration studies). In vitro hematopoietic progenitor transformation assays were performed as MSCV/MLL-GAS7 contains one internal BamHI site and no ScaI sites. Dipreviously described Cleary, 2002, 2003) except for differences in gested DNAs were separated in 0.8% agarose, transferred to nylon memthe preparation of enriched/purified hematopoietic stem/progenitors cells.
branes, and hybridized with radiolabeled DNA probes. JH4-and J-specific Partial or highly purified hematopoietic cells were prepared from the bone probes were used for Ig heavy and light chain gene assessment, respectively. marrow of 4-to 10-week-old Ly5.2 C57BL/6 mice by (1) pretreatment with For MSCV/MLL-GAS7 retroviral integration studies, a human MLL cDNA 5-fluorouracil (5-FU) (100 mg/kg) 5 days before bone marrow harvesting; (2) probe (Tkachuk et al., 1992) spanning nucleotides 3295-3726 (accession positive selection for c-kit expression by magnetic activated cell sorting number NM_005933) was employed. (MACS); or (3) fluorescent activated cell sorting (FACS) using specific antibodies to defined cell surface markers for various hematopoietic stem and Western blot and RT-PCR analyses progenitor cells as previously described (Morrison and Weissman, 1994;  Lysate proteins (30 g) were fractionated in 5% polyacylamide gel and Kondo et al., 1997; Morrison et al., 1997; Akashi et al., 2000) . Phenotypic transferred to ECL membranes (Amersham Pharmacia Biotech) using Trispopulations were defined as HSC (Lin Ϫ/lo /Thy1.1 lo /c-kit hi /Sca-1 hi ), CLP (Lin Ϫ / glycine-SDS transfer buffer. After blocking, membranes were probed with c-kit lo /Sca-1 lo /IL-7R lo /Thy1.1 Ϫ ), CMP (c-kit hi /Sca-1 Ϫ /CD34 ϩ /CD16/32 lo ), GMP monoclonal antibody N4.4 directed against an MLL amino-terminal epitope as previously described Cleary, 2002, 2003) . Total RNAs purified (Lin Ϫ /c-kit hi /Sca-1 Ϫ /CD34 ϩ /CD16/32 hi ), and MEP (Lin Ϫ /c-kit hi /Sca-1 Ϫ /
